Stem cells for the heart, are we there yet?

被引:14
|
作者
Timmermans, F [1 ]
De Sutter, J [1 ]
Gillebert, TC [1 ]
机构
[1] Univ Ghent, Dept Cardiovasc Dis, B-9000 Ghent, Belgium
关键词
stem cells; myocardial infarction; delivery; differentiation; adverse effects;
D O I
10.1159/000074811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although several repair mechanisms have been described in the human heart, all fall too short to prevent clinical heart disease in most acute or chronic pathological cardiac conditions. Moreover, despite many breakthroughs in cardiovascular medicine, the complications of a myocardial infarction such as chronic heart failure remains a serious worldwide problem. Bone marrow stem cells could provide for a promising strategy to restore myocardial infarctions and prevent postinfarct congestive heart failure, because there is growing body of evidence that bone marrow stem cells, such as mesenchymal stem cells, can generate new cardiomyocytes in animals and humans. In this review, we will discuss important issues on stem cell therapy for cardiac regeneration after myocardial infarction, which might be of paramount importance when considering future human trials. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:176 / 185
页数:10
相关论文
共 50 条
  • [21] Cancer stem cell targeting: Are we there yet?
    Yuchae Jung
    Woo-Young Kim
    Archives of Pharmacal Research, 2015, 38 : 414 - 422
  • [22] Update in Artificial Heart Technology: Are We There Yet?
    Tchantchaleishvili, Vakhtang
    Phillips, Steven J.
    ARTIFICIAL ORGANS, 2016, 40 (12) : 1099 - 1100
  • [23] Personalized Medicine in Heart Failure Are We There Yet?
    Yancy, Clyde W.
    Lee, Daniel C.
    JACC-CARDIOVASCULAR IMAGING, 2012, 5 (04) : 419 - 421
  • [24] Heart transplantation in India-are we there yet?
    Balakrishnan, Komarakshi
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 36 (SUPPL 2) : 159 - 165
  • [25] Biomarkers for the Prevention of Heart Failure Are We There Yet?
    Felker, G. Michael
    Ahmad, Tariq
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (25) : 3255 - 3258
  • [26] In-Vitro Stem Cell Derived Red Blood Cells for Transfusion: Are We There Yet?
    Kim, Hyun Ok
    YONSEI MEDICAL JOURNAL, 2014, 55 (02) : 304 - 309
  • [27] Tissue engineering craniofacial defects with adult. stem cells? Are we ready yet?
    Zuk, Patricia A.
    PEDIATRIC RESEARCH, 2008, 63 (05) : 478 - 486
  • [28] Are we there yet? Are we there yet?
    Conrad, Charles
    Malphurs, Ryan
    MANAGEMENT COMMUNICATION QUARTERLY, 2008, 22 (01) : 123 - 146
  • [29] Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?
    Ezzat, Tarek M.
    Dhar, Dipok K.
    Newsome, Philip N.
    Malago, Massimo
    Damink, Steven W. M. Olde
    LIVER INTERNATIONAL, 2011, 31 (06) : 775 - 786
  • [30] Restoring Fertility in Sterile Childhood Cancer Survivors by Autotransplanting Spermatogonial Stem Cells: Are We There Yet?
    Struijk, Robert B.
    Mulder, Callista L.
    van der Veen, Fulco
    van Pelt, Ans M. M.
    Repping, Sjoerd
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013